Showing results (1951-1960 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|November 27, 2014
Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and managementDaniel Luedecke, Daniel Schöttle, Anne Karow, et al.CNS Drugs|August 22, 2015
The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation AntipsychoticsMarc De Hert, Jan Sermon, Paul Geerts, et al.CNS Drugs|December 12, 2018
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release FampridineJeremy Hobart, Tjalf Ziemssen, Peter Feys, et al.CNS Drugs|August 16, 2017
Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and ManagementKathlyn J RonaldsonCNS Drugs|March 28, 2018
Newer Antiepileptic Drugs for Status Epilepticus in Adults: What's the Evidence?Isabelle Beuchat, Jan Novy, Andrea O RossettiCNS Drugs|November 6, 2019
Ischemic and Thrombotic Events Associated with Concomitant Xa-inhibiting Direct Oral Anticoagulants and Antiepileptic Drugs: Analysis of the FDA Adverse Event Reporting System (FAERS)Amichai Perlman, Maor Wanounou, Rachel Goldstein, et al.CNS Drugs|February 13, 2019
Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing PotentialAnna Serafini, Elizabeth Gerard, Pierre Genton, et al.CNS Drugs|February 1, 2018
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine DimesylateDavid R Coghill, Tobias Banaschewski, Caleb Bliss, et al.CNS Drugs|May 31, 2022
Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic MedicationsYves Dauvilliers, Karel Šonka, Richard K Bogan, et al.CNS Drugs|May 31, 2021
Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its UseJulia PaikPageof 211